OBJECTIVE: This study aimed to examine the contributions of coping and social constraint to disease activity and health-related quality of life (HRQOL) and to examine group differences in disease activity and HRQOL between patients with high versus low anxiety or depression symptoms in adults with inflammatory bowel disease (IBD). METHODS: This study was a retrospective analysis in which disease activity was measured with either the Harvey-Bradshaw Index or the Simple Clinical Colitis Activity Index. HRQOL was measured with the Short Inflammatory Bowel Disease Questionnaire. Coping was measured with a modified COPE questionnaire. Anxiety and depression symptoms were measured with the Hospital Anxiety and Depression Scale. Social constraint was measured with the Social Constraint Questionnaire. Correlational and regression analyses were performed to assess the relationships between social constraint, coping, anxiety symptoms, depression symptoms, and HRQOL and disease activity. RESULTS: Data from 80 adults with IBD were reviewed. Social constraint, disengagement coping, anxiety symptoms, and depression symptoms were inversely correlated with HRQOL. Disengagement coping was positively correlated with disease activity. Regression analyses showed that smokers had significantly worse HRQOL than nonsmokers and that greater use of engagement coping was associated with significantly diminished HRQOL. Regression analyses also showed that patients diagnosed between 17 and 40 years of age were significantly less likely to have active disease than patients diagnosed before 16 years of age and that greater use of disengagement coping was associated with increased odds of having active disease. CONCLUSIONS: Medical providers should be aware that coexisting social constraint and symptoms of anxiety and depression are common in patients with IBD. Screening for these factors, as well as patients' coping styles, should be strongly considered, and patients should be referred to mental health providers as appropriate.
OBJECTIVE: This study aimed to examine the contributions of coping and social constraint to disease activity and health-related quality of life (HRQOL) and to examine group differences in disease activity and HRQOL between patients with high versus low anxiety or depression symptoms in adults with inflammatory bowel disease (IBD). METHODS: This study was a retrospective analysis in which disease activity was measured with either the Harvey-Bradshaw Index or the Simple Clinical Colitis Activity Index. HRQOL was measured with the Short Inflammatory Bowel Disease Questionnaire. Coping was measured with a modified COPE questionnaire. Anxiety and depression symptoms were measured with the Hospital Anxiety and Depression Scale. Social constraint was measured with the Social Constraint Questionnaire. Correlational and regression analyses were performed to assess the relationships between social constraint, coping, anxiety symptoms, depression symptoms, and HRQOL and disease activity. RESULTS: Data from 80 adults with IBD were reviewed. Social constraint, disengagement coping, anxiety symptoms, and depression symptoms were inversely correlated with HRQOL. Disengagement coping was positively correlated with disease activity. Regression analyses showed that smokers had significantly worse HRQOL than nonsmokers and that greater use of engagement coping was associated with significantly diminished HRQOL. Regression analyses also showed that patients diagnosed between 17 and 40 years of age were significantly less likely to have active disease than patients diagnosed before 16 years of age and that greater use of disengagement coping was associated with increased odds of having active disease. CONCLUSIONS: Medical providers should be aware that coexisting social constraint and symptoms of anxiety and depression are common in patients with IBD. Screening for these factors, as well as patients' coping styles, should be strongly considered, and patients should be referred to mental health providers as appropriate.
Authors: Lesley A Graff; John R Walker; Ian Clara; Lisa Lix; Norine Miller; Linda Rogala; Patricia Rawsthorne; Charles N Bernstein Journal: Am J Gastroenterol Date: 2009-09-15 Impact factor: 10.864
Authors: Swathi Eluri; Raymond K Cross; Christopher Martin; Kevin P Weinfurt; Kathryn E Flynn; Millie D Long; Wenli Chen; Kristen Anton; Robert S Sandler; Michael D Kappelman Journal: Dig Dis Sci Date: 2018-03-21 Impact factor: 3.199
Authors: Benjamin Click; Alyce M Anderson; Claudia Ramos Rivers; Ioannis E Koutroubakis; Jana G Hashash; Michael A Dunn; Marc Schwartz; Jason Swoger; Arthur Barrie; Eva Szigethy; Miguel Regueiro; Robert E Schoen; David G Binion Journal: J Clin Gastroenterol Date: 2018-04 Impact factor: 3.062
Authors: Benjamin Click; Claudia Ramos Rivers; Ioannis E Koutroubakis; Dmitriy Babichenko; Alyce M Anderson; Jana G Hashash; Michael A Dunn; Marc Schwartz; Jason Swoger; Leonard Baidoo; Arthur Barrie; Miguel Regueiro; David G Binion Journal: Inflamm Bowel Dis Date: 2016-06 Impact factor: 5.325
Authors: Laura Katz; Dean A Tripp; Mark Ropeleski; William Depew; J Curtis Nickel; Stephen Vanner; Michael J Beyak Journal: J Clin Psychol Med Settings Date: 2016-03
Authors: Rachel L Randell; Millie D Long; Christopher F Martin; Robert S Sandler; Wenli Chen; Kristen Anton; Michael D Kappelman Journal: Inflamm Bowel Dis Date: 2013-06 Impact factor: 5.325